Meghana Keshavan from STAT News - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting		Inhaled vaccines could stop Covid infections, monkey studies show - 5 months ago The biotech updates you need to read today - 5 months ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 5 months ago FDA chastens pet companies over antibiotics - 5 months ago The biotech news you missed from the weekend - 5 months ago CRISPR is about to make history. Here’s the 5-minute rundown of what to expect - 5 months ago Novartis is building a new radioligand plant in China - 6 months ago Johnson & Johnson bets heavy on AI-driven drug discovery - 6 months ago Today’s biotech news roundup, in under 800 words - 6 months ago A new algorithm unveils CRISPR ‘treasure trove’ - 6 months ago Merck cough drug doesn’t pass panel scrutiny - 6 months ago These are the need-to-know biotech stories from this weekend - 6 months ago The first vaccine for the increasingly prevalent chikungunya virus is here - 6 months ago XBI biotech index rises, giving investors a shred of hope - 6 months ago Shrinking Covid vaccine sales has Moderna course-correcting - 7 months ago Your Monday morning biotech news roundup - 7 months ago Regeneron gene therapy improves hearing in child - 7 months ago Johnson & Johnson antiviral pill for dengue shows early efficacy - 7 months ago Why Biogen is purposefully becoming more risk averse, according to Biogen’s CEO - 7 months ago Candor on gene therapy, Abiomed is warned, & BTK success in MS - 7 months ago Want a biotech buyout? Target cancer - 7 months ago NIH funds expanded access projects for ALS - 7 months ago